Drugs / 11C-M503
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06303921 | Feb 2024 → Feb 2029 expected | tauopathy | University of Pennsylvania | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 11C-M503 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06303921 ↗ |
| Modality | Diagnostic / imaging agent | “2 hour Positron Emission Tomography (PET) scan using new radiotracer 11C-M503” NCT06303921 ↗ |